Browse diseases

…se results demonstrate increased levels of protease activity in IBD patients relative to HC. They also show higher levels in IBD pa…

…or 51.1% of patients. Patients predominantly had a diagnosis of ulcerative colitis (n=994), followed by Crohn’s disease (n=409) and IBD-unclassifi…

…e with a mean age of diagnosis of 32.7 (SD 16) years. 49.1% had ulcerative colitis (n = 1991), 46.5% Crohn’s disease (n = 1889) and 4.4% IBD-U (n …

…sion through W52 in patients with moderately-to-severely active Crohn’s disease (CD). We present maintenance outcomes analysis through W52 for …

…nfluence of poor psychological health on the natural history of inflammatory bowel disease (IBD), a better understanding of resilience and its association…

…ekinumab is an effective treatment for Crohn’s disease (CD) and ulcerative colitis (UC). The advent of biosimilar ustekinumab in 2024 and potentia…

…ic inflammatory mucosal organoid model with mucus production in ulcerative colitis (UC) by sampling inflamed and non-inflamed mucosal tissue. Thes…

…those with IBD and worse disease outcomes. However, living with IBD also makes people more susceptible to post traumatic stress (PT…

…xFemale20 (41%)Male29 (59%)IBD subtypeUlcerative colitis37 (76%)Crohn’s disease9 (18%)Indeterminate colitis3 (6%)Primary sclerosing cholangitis4…

…d Wales (71/76), Azathioprine monotherapy is used first line in ulcerative colitis (33,46.5%) and Crohn’s disease (22,31.0%). Across the UK anti-T…

…an age 54 years; 9% with primary sclerosing cholangitis [PSC]). Ulcerative colitis (UC) was the most common diagnosis (66.8%), followed by Crohn’s…

…Introduction Mycobacterium avium subspecies paratuberculosis (MAP) remains a potential contributor to the pathogenesis of Cr…